Adam Feinberg

Chief Technology Officer at FluidForm Bio

Adam Feinberg serves as a Professor at Carnegie Mellon University, with appointments in the Departments of Biomedical Engineering, Materials Science and Engineering, and Mechanical Engineering, in addition to affiliation with the McGowan Institute for Regenerative Medicine. Adam also holds the position of CTO and co-founder at FluidForm, starting in June 2018. Prior to these roles, Adam was an Associate Professor and Assistant Professor at Carnegie Mellon University, and worked as a Postdoctoral Fellow in Cardiac Tissue Engineering at Harvard University from 2005 to 2010. Adam Feinberg earned a Bachelor of Science degree in Materials Science and Engineering from Cornell University, followed by a Master of Science and a PhD in Biomedical Engineering from the University of Florida.

Location

Pittsburgh, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


FluidForm Bio

FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications.    We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options. 


Employees

11-50

Links